Gennova Biopharmaceuticals Ltdis A Biotechnology Company Based In Punemaharashtraindiathe Company Specializes In The Researchdevelopmentproductionand Commercialization Of Biotherapeutics And Vaccines Aimed At Treating Life Threatening Diseases In Areas Such As Cardiovascularneurologynephrologyand Oncology Gennova Employs Advanced Recombinant Dna Technologies And Innovative Bio Manufacturing Practices To Create Effective Biotherapeutic Solutionsthe Company Utilizes Various Expression Platformsincluding Bacterialmammalianand Yeast Based Systemsto Produce Its Recombinant Productsgennova Has Successfully Commercialized Seven Productsincluding Tenectasea Biosimilar For Treating Acute Ischemic Strokeand Hamsyla Treatment For Acute Lymphoblastic Lymphoma Offered At A Lower Price Point For Better Accessibility With A Strong Focus On Research And Developmentgennova Is Recognized As A Preferred Partner In The Vaccine Sector For Research And Cgmp Manufacturingthe Company Employs Around 598 People And Has Reported A Revenue Of $2 8 Millionpositioning Itself As A Notable Player In The Indian Biotechnology Landscape
